RIVERPARK ADVISORS, LLC Biotech Acquisition Company Transaction History

RIVERPARK ADVISORS, LLC portfolio value:

$7.93M
portfolio value

RIVERPARK ADVISORS, LLC quarter portfolio value change:

+0.20%
quarter

Biotech Acquisition Company 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share 0.00% 0 shares 20K $9.92 799.00K
Q2 2022 share 0.00% 0 shares 40K $9.9 799.00K
Q1 2022 share 0.00% 0 shares 8K $9.86 799.00K
Q4 2021 share Increase 0.00% 799.00K shares 7.86M $9.83 799.00K